EE+ POEM Archive
Darbepoetin alfa minimally effective, increases stroke risk in diabetic nephropathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Darbepoetin Alfa Minimally Effective, Increases Stroke Risk in Diabetic Nephropathy." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/426921/all/Darbepoetin_alfa_minimally_effective_increases_stroke_risk_in_diabetic_nephropathy.
Darbepoetin alfa minimally effective, increases stroke risk in diabetic nephropathy. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426921/all/Darbepoetin_alfa_minimally_effective_increases_stroke_risk_in_diabetic_nephropathy. Accessed April 20, 2024.
Darbepoetin alfa minimally effective, increases stroke risk in diabetic nephropathy. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426921/all/Darbepoetin_alfa_minimally_effective_increases_stroke_risk_in_diabetic_nephropathy
Darbepoetin Alfa Minimally Effective, Increases Stroke Risk in Diabetic Nephropathy [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426921/all/Darbepoetin_alfa_minimally_effective_increases_stroke_risk_in_diabetic_nephropathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Darbepoetin alfa minimally effective, increases stroke risk in diabetic nephropathy
ID - 426921
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426921/all/Darbepoetin_alfa_minimally_effective_increases_stroke_risk_in_diabetic_nephropathy
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
